Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.1353 per EA under NDC 00378300377. Its NADAC has been published 648 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the candesartan cilexetil and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB
candesartan cilexetil and hydrochlorothiazideStrength
32; 25 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378300377
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090704On Market Since
12/4/2012
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has been published 648 times since Nov 28, 2013, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1353 per EA |
|---|---|
| All-time high | $4.1187 (Mar 13, 2019) |
| All-time low | $0.9491 (Oct 22, 2025) |
| 52-week high | $1.2433 |
| 52-week low | $0.9491 |
| Median price | $2.1077 |
| Average price | $2.3054 |
| Largest weekly change | +149.4% (Apr 21, 2021) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $1.1353 per EA (NDC 00378300377), effective Jun 24, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has declined 59.0%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
Since Nov 28, 2013, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has ranged from a low of $0.9491 (Oct 22, 2025) to a high of $4.1187 (Mar 13, 2019), with a median of $2.1077 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB (NDC 00378300377) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification